Transaction valued at $156.00 per Hillrom Share for an All-Cash Purchase Price of $10.5 Billion
Brings together two leading medical technology companies to broaden access to care in the hospital, home and alternate site settings
Accelerates digitally-enabled connected care solutions across the continuum of care
Builds on Baxter’s global footprint to expand Hillrom’s penetration of international markets
Creates significant opportunities to position Baxter for faster top- and bottom-line growth
Expected to generate high single-digit ROIC by year five
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.